Copies of the agreement should be printed for each party – specialist and family physician – to accept, sign and keep. The Committee on Drug Optimization agreed that if general practice refuses to reach an agreement on the joint supply of a drug deemed appropriate by NICE for joint treatment, the physician should finalize the proform for the AEAR, which has been rejected by general practice, so that the trust can impose an adequate burden on the GCC. A Common Care Agreement (SAC) provides avenues for allocating drug prescribing management responsibilities between the specialist and the family physician. The purpose of these documents is to provide the family physician with sufficient information to prescribe drugs that can be maintained in primary care. In order to provide the family physician with all the essential information and a link between primary and secondary care if the family doctor has other questions, doctors within SaTH must print and fill out the information contained in this document and send it to the family doctor in the same way as an ESCA. Click on your area below to continue. Drugs are categobated in the BNF. If the drug you are looking for is not mentioned, then there is currently no common care available. Agreement on effective joint care can contribute to the smooth transmission of treatment of patients from secondary to general practice, as it provides information on the drug as well as guidelines for prescribing and monitoring tasks. They are individually to a particular drug, in detail, which is responsible for what aspect of care and when early referral to specialized services is needed. They allow for the smooth transition from the liability of prescribing specialized services to general practice. The common use of care involves communication between the specialist, the family physician and the patient (and/or the caregiver).
The intention to share care must be explained to the patient by the doctor who introduces the treatment. It is important that patients are consulted on treatment and agree. Patients receiving the given medication should be followed regularly, which provides opportunities to discuss drug therapy. The CSEs that have been set up in the trust and agreed with our local CCGs are listed below. Other CSEs can be find on the Telford-Wrekin CCG and Shropshire CCG websites. (The patient`s CCG is determined by the CGC for the patient`s family physician`s office). In accordance with national Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, the Trust complies with NICE`s recommendations for the commissioning of medicines and treatments (more information).